See the DrugPatentWatch profile for tigecycline

Based on the information available, it can be inferred that patients may have better access to tigecycline following its generic availability. Tigecycline is an antibiotic used to treat various bacterial infections, and its patent expired in 2015, allowing other manufacturers to produce and sell generic versions of the drug [1].

The availability of generic drugs typically leads to increased competition among manufacturers, which can result in lower prices for patients and healthcare providers [2]. Consequently, this may increase the accessibility of tigecycline for patients, as the reduced cost could make it more affordable and accessible for a larger number of individuals.

However, it is important to note that other factors may also impact patients' access to tigecycline. For instance, formulary decisions by insurance companies and pharmacy benefit managers can influence whether or not a drug is covered and how much patients pay out-of-pocket [3]. Additionally, the availability of generic drugs can vary by location, as some pharmacies may not carry all generic medications [4].

In summary, the availability of generic tigecycline may have a positive impact on patients' access to the drug, but other factors can influence its accessibility.

Sources:
[1] DrugPatentWatch.com. (n.d.). Tigecycline. Retrieved from https://www.drugpatentwatch.com/drugs/tigecycline
[2] U.S. Food and Drug Administration. (2018, March 8). Generic Drugs: Questions and Answers. Retrieved from https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/generic-drugs-questions-and-answers
[3] National Conference of State Legislatures. (2019, August 21). Prescription Drug Costs: State Efforts to Address. Retrieved from https://www.ncsl.org/research/health/prescription-drug-costs-state-efforts-to-address.aspx
[4] National Center for Biotechnology Information. (2021, March 11). Generic Drugs. Retrieved from https://medlineplus.gov/ency/patientinstructions/000333.htm